5-(5-benzyl-16-ethynyl-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl)-3-propan-2-yl-1,2,4-oxadiazole;3-[9-(cyclohexyloxymethyl)-15-ethynyl-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;5-cyclopropyl-3-[16-ethynyl-5-[(4-fluorophenoxy)methyl]-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-1,2,4-oxadiazole;3-[9-(cyclopropyloxymethyl)-15-ethynyl-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-ethynyl-5-(pyridin-3-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole

C126H107FN36O8 — CID 167674501

About 5-(5-benzyl-16-ethynyl-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl)-3-propan-2-yl-1,2,4-oxadiazole;3-[9-(cyclohexyloxymethyl)-15-ethynyl-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;5-cyclopropyl-3-[16-ethynyl-5-[(4-fluorophenoxy)methyl]-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-1,2,4-oxadiazole;3-[9-(cyclopropyloxymethyl)-15-ethynyl-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-ethynyl-5-(pyridin-3-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole

5-(5-benzyl-16-ethynyl-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl)-3-propan-2-yl-1,2,4-oxadiazole;3-[9-(cyclohexyloxymethyl)-15-ethynyl-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;5-cyclopropyl-3-[16-ethynyl-5-[(4-fluorophenoxy)methyl]-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-1,2,4-oxadiazole;3-[9-(cyclopropyloxymethyl)-15-ethynyl-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-ethynyl-5-(pyridin-3-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole (PubChem CID 167674501) has the molecular formula C126H107FN36O8 and a molecular weight of 2272.48 g/mol. Its IUPAC name is 5-(5-benzyl-16-ethynyl-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl)-3-propan-2-yl-1,2,4-oxadiazole;3-[9-(cyclohexyloxymethyl)-15-ethynyl-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;5-cyclopropyl-3-[16-ethynyl-5-[(4-fluorophenoxy)methyl]-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-1,2,4-oxadiazole;3-[9-(cyclopropyloxymethyl)-15-ethynyl-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-ethynyl-5-(pyridin-3-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole.

Molecular Properties

• Compound Name: 5-(5-benzyl-16-ethynyl-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl)-3-propan-2-yl-1,2,4-oxadiazole;3-[9-(cyclohexyloxymethyl)-15-ethynyl-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;5-cyclopropyl-3-[16-ethynyl-5-[(4-fluorophenoxy)methyl]-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-1,2,4-oxadiazole;3-[9-(cyclopropyloxymethyl)-15-ethynyl-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-ethynyl-5-(pyridin-3-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole
• PubChem CID: 167674501
• Molecular Formula: C126H107FN36O8
• Molecular Weight: 2272.48 g/mol
• Exact Mass: 2270.91
• IUPAC Name: 5-(5-benzyl-16-ethynyl-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl)-3-propan-2-yl-1,2,4-oxadiazole;3-[9-(cyclohexyloxymethyl)-15-ethynyl-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;5-cyclopropyl-3-[16-ethynyl-5-[(4-fluorophenoxy)methyl]-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-1,2,4-oxadiazole;3-[9-(cyclopropyloxymethyl)-15-ethynyl-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-ethynyl-5-(pyridin-3-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole
• SMILES: C#Cc1ccc2c(c1)-c1nnc(COC3CC3)n1Cc1c(-c3noc(C(C)C)n3)ncn1-2.C#Cc1ccc2c(c1)-c1nnc(COC3CCCCC3)n1Cc1c(-c3noc(C(C)C)n3)ncn1-2.C#Cc1ccc2c(c1)-n1nnc(COc3ccc(F)cc3)c1Cc1c(-c3noc(C4CC4)n3)ncn1-2.C#Cc1ccc2c(c1)-n1nnc(Cc3ccccc3)c1Cc1c(-c3nc(C(C)C)no3)ncn1-2.C#Cc1ccc2c(c1)-n1nnc(Cc3cccnc3)c1Cc1c(-c3noc(C(C)C)n3)ncn1-2
• InChI: InChI=1S/C26H18FN7O2.C26H27N7O2.C26H21N7O.C25H20N8O.C23H21N7O2/c1-2-15-3-10-20-22(11-15)34-21(19(30-32-34)13-35-18-8-6-17(27)7-9-18)12-23-24(28-14-33(20)23)25-29-26(36-31-25)16-4-5-16;1-4-17-10-11-20-19(12-17)25-30-29-22(14-34-18-8-6-5-7-9-18)32(25)13-21-23(27-15-33(20)21)24-28-26(16(2)3)35-31-24;1-4-17-10-11-20-22(13-17)33-21(19(29-31-33)12-18-8-6-5-7-9-18)14-23-24(27-15-32(20)23)26-28-25(16(2)3)30-34-26;1-4-16-7-8-19-21(11-16)33-20(18(29-31-33)10-17-6-5-9-26-13-17)12-22-23(27-14-32(19)22)24-28-25(15(2)3)34-30-24;1-4-14-5-8-17-16(9-14)22-27-26-19(11-31-15-6-7-15)29(22)10-18-20(24-12-30(17)18)21-25-23(13(2)3)32-28-21/h1,3,6-11,14,16H,4-5,12-13H2;1,10-12,15-16,18H,5-9,13-14H2,2-3H3;1,5-11,13,15-16H,12,14H2,2-3H3;1,5-9,11,13-15H,10,12H2,2-3H3;1,5,8-9,12-13,15H,6-7,10-11H2,2-3H3
• InChIKey: UPPQQCVPIZIJGF-UHFFFAOYSA-N
• XLogP: 19.41
• TPSA: 477.83 Ų
• H-Bond Acceptors: 44
• Rotatable Bonds: 23
• Heavy Atoms: 171
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	2272.48
LogP ≤ 5	19.41
H-Bond Donors ≤ 5	0
H-Bond Acceptors ≤ 10	44

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'triple_bond', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 5-(5-benzyl-16-ethynyl-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl)-3-propan-2-yl-1,2,4-oxadiazole;3-[9-(cyclohexyloxymethyl)-15-ethynyl-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;5-cyclopropyl-3-[16-ethynyl-5-[(4-fluorophenoxy)methyl]-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-1,2,4-oxadiazole;3-[9-(cyclopropyloxymethyl)-15-ethynyl-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-ethynyl-5-(pyridin-3-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole?

The IUPAC name of 5-(5-benzyl-16-ethynyl-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl)-3-propan-2-yl-1,2,4-oxadiazole;3-[9-(cyclohexyloxymethyl)-15-ethynyl-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;5-cyclopropyl-3-[16-ethynyl-5-[(4-fluorophenoxy)methyl]-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-1,2,4-oxadiazole;3-[9-(cyclopropyloxymethyl)-15-ethynyl-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-ethynyl-5-(pyridin-3-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole (CID 167674501) is 5-(5-benzyl-16-ethynyl-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl)-3-propan-2-yl-1,2,4-oxadiazole;3-[9-(cyclohexyloxymethyl)-15-ethynyl-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;5-cyclopropyl-3-[16-ethynyl-5-[(4-fluorophenoxy)methyl]-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-1,2,4-oxadiazole;3-[9-(cyclopropyloxymethyl)-15-ethynyl-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-ethynyl-5-(pyridin-3-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole.

What is the SMILES notation for 5-(5-benzyl-16-ethynyl-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl)-3-propan-2-yl-1,2,4-oxadiazole;3-[9-(cyclohexyloxymethyl)-15-ethynyl-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;5-cyclopropyl-3-[16-ethynyl-5-[(4-fluorophenoxy)methyl]-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-1,2,4-oxadiazole;3-[9-(cyclopropyloxymethyl)-15-ethynyl-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-ethynyl-5-(pyridin-3-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole?

The canonical SMILES for 5-(5-benzyl-16-ethynyl-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl)-3-propan-2-yl-1,2,4-oxadiazole;3-[9-(cyclohexyloxymethyl)-15-ethynyl-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;5-cyclopropyl-3-[16-ethynyl-5-[(4-fluorophenoxy)methyl]-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-1,2,4-oxadiazole;3-[9-(cyclopropyloxymethyl)-15-ethynyl-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-ethynyl-5-(pyridin-3-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole is C#Cc1ccc2c(c1)-c1nnc(COC3CC3)n1Cc1c(-c3noc(C(C)C)n3)ncn1-2.C#Cc1ccc2c(c1)-c1nnc(COC3CCCCC3)n1Cc1c(-c3noc(C(C)C)n3)ncn1-2.C#Cc1ccc2c(c1)-n1nnc(COc3ccc(F)cc3)c1Cc1c(-c3noc(C4CC4)n3)ncn1-2.C#Cc1ccc2c(c1)-n1nnc(Cc3ccccc3)c1Cc1c(-c3nc(C(C)C)no3)ncn1-2.C#Cc1ccc2c(c1)-n1nnc(Cc3cccnc3)c1Cc1c(-c3noc(C(C)C)n3)ncn1-2.

What is the InChIKey of 5-(5-benzyl-16-ethynyl-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl)-3-propan-2-yl-1,2,4-oxadiazole;3-[9-(cyclohexyloxymethyl)-15-ethynyl-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;5-cyclopropyl-3-[16-ethynyl-5-[(4-fluorophenoxy)methyl]-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-1,2,4-oxadiazole;3-[9-(cyclopropyloxymethyl)-15-ethynyl-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-ethynyl-5-(pyridin-3-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole?

The InChIKey is UPPQQCVPIZIJGF-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H18FN7O2.C26H27N7O2.C26H21N7O.C25H20N8O.C23H21N7O2/c1-2-15-3-10-20-22(11-15)34-21(19(30-32-34)13-35-18-8-6-17(27)7-9-18)12-23-24(28-14-33(20)23)25-29-26(36-31-25)16-4-5-16;1-4-17-10-11-20-19(12-17)25-30-29-22(14-34-18-8-6-5-7-9-18)32(25)13-21-23(27-15-33(20)21)24-28-26(16(2)3)35-31-24;1-4-17-10-11-20-22(13-17)33-21(19(29-31-33)12-18-8-6-5-7-9-18)14-23-24(27-15-32(20)23)26-28-25(16(2)3)30-34-26;1-4-16-7-8-19-21(11-16)33-20(18(29-31-33)10-17-6-5-9-26-13-17)12-22-23(27-14-32(19)22)24-28-25(15(2)3)34-30-24;1-4-14-5-8-17-16(9-14)22-27-26-19(11-31-15-6-7-15)29(22)10-18-20(24-12-30(17)18)21-25-23(13(2)3)32-28-21/h1,3,6-11,14,16H,4-5,12-13H2;1,10-12,15-16,18H,5-9,13-14H2,2-3H3;1,5-11,13,15-16H,12,14H2,2-3H3;1,5-9,11,13-15H,10,12H2,2-3H3;1,5,8-9,12-13,15H,6-7,10-11H2,2-3H3.

What are the key properties of 5-(5-benzyl-16-ethynyl-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl)-3-propan-2-yl-1,2,4-oxadiazole;3-[9-(cyclohexyloxymethyl)-15-ethynyl-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;5-cyclopropyl-3-[16-ethynyl-5-[(4-fluorophenoxy)methyl]-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-1,2,4-oxadiazole;3-[9-(cyclopropyloxymethyl)-15-ethynyl-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-ethynyl-5-(pyridin-3-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole?

5-(5-benzyl-16-ethynyl-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl)-3-propan-2-yl-1,2,4-oxadiazole;3-[9-(cyclohexyloxymethyl)-15-ethynyl-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;5-cyclopropyl-3-[16-ethynyl-5-[(4-fluorophenoxy)methyl]-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-1,2,4-oxadiazole;3-[9-(cyclopropyloxymethyl)-15-ethynyl-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-ethynyl-5-(pyridin-3-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole has a molecular weight of 2272.48 g/mol, XLogP of 19.41, 23 rotatable bonds, 0 hydrogen bond donors, and 44 hydrogen bond acceptors.

Where does this data come from?

All data for 5-(5-benzyl-16-ethynyl-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl)-3-propan-2-yl-1,2,4-oxadiazole;3-[9-(cyclohexyloxymethyl)-15-ethynyl-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;5-cyclopropyl-3-[16-ethynyl-5-[(4-fluorophenoxy)methyl]-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-1,2,4-oxadiazole;3-[9-(cyclopropyloxymethyl)-15-ethynyl-2,4,8,10,11-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,9,11,14,16-heptaen-5-yl]-5-propan-2-yl-1,2,4-oxadiazole;3-[16-ethynyl-5-(pyridin-3-ylmethyl)-2,3,4,10,12-pentazatetracyclo[11.4.0.02,6.08,12]heptadeca-1(13),3,5,8,10,14,16-heptaen-9-yl]-5-propan-2-yl-1,2,4-oxadiazole is sourced from PubChem (CID 167674501), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).